PolyPid Announces Positive Recommendation by Dsmb to Continue Enrollment of Phase 3 Shield II Trial of D-Plex₁₀₀ to 800 Patients With a Concurrent Private Placement of up to $41 Million
PolyPid宣佈Dsmb對D-Plex₁₀₀的第3期Shield II試驗繼續招募800名患者的積極建議，同時進行定向增發，最高可達4100萬美金
